Aelis Farma S.A.
AELIS.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | €2,678 | €9,054 | €3,809 | €9,075 |
| % Growth | -70.4% | 137.7% | -58% | – |
| Cost of Goods Sold | €0 | €0 | €0 | €0 |
| Gross Profit | €2,678 | €9,054 | €3,809 | €9,075 |
| % Margin | 100% | 100% | 100% | 100% |
| R&D Expenses | €9,942 | €16,212 | €13,792 | €6,870 |
| G&A Expenses | €3,355 | €1,097 | €1,670 | €562 |
| SG&A Expenses | €3,355 | €1,097 | €1,670 | €562 |
| Sales & Mktg Exp. | €0 | €0 | €0 | €0 |
| Other Operating Expenses | €0 | €1,510 | -€3,129 | -€908 |
| Operating Expenses | €13,297 | €18,819 | €12,333 | €6,524 |
| Operating Income | -€7,735 | -€6,461 | -€8,525 | €2,552 |
| % Margin | -288.8% | -71.4% | -223.8% | 28.1% |
| Other Income/Exp. Net | €287 | €1,386 | -€5,762 | -€793 |
| Pre-Tax Income | -€7,448 | -€5,075 | -€14,287 | €1,759 |
| Tax Expense | €8 | €3 | €1 | €1,185 |
| Net Income | -€7,456 | -€5,078 | -€14,288 | €574 |
| % Margin | -278.4% | -56.1% | -375.1% | 6.3% |
| EPS | -0.54 | -0.39 | -1.21 | 0.06 |
| % Growth | -38.5% | 67.8% | -2,123.4% | – |
| EPS Diluted | -0.54 | -0.39 | -1.21 | 0.06 |
| Weighted Avg Shares Out | 13,706 | 12,899 | 11,840 | 9,593 |
| Weighted Avg Shares Out Dil | 13,706 | 12,899 | 11,840 | 9,593 |
| Supplemental Information | – | – | – | – |
| Interest Income | €493 | €419 | €52 | €1 |
| Interest Expense | €206 | €157 | €112 | €140 |
| Depreciation & Amortization | -€1,170 | €168 | €70 | €35 |
| EBITDA | -€8,618 | -€6,347 | -€16,227 | €844 |
| % Margin | -321.8% | -70.1% | -426% | 9.3% |